Camillo Ricordi, M.D., born on April 1, 1957, concluded his graduate/post-graduate studies and his surgical residency with the highest scores and honors. Dr. Ricordi is the Stacy Joy Goodman Professor of Surgery and Medicine and Chief of the Division of Cellular Transplantation, at the University of Miami School of Medicine. In September 1996, he assumed the position of Scientific Director and Chief Academic Officer of the Diabetes Research Institute.
Prior to joining the DRI, Dr. Ricordi served as Attending Surgeon at the San Raffaele Institute, University of Milan School of Medicine (1988-1989). He then spent four years as Associate Professor of Surgery and Director of Cellular Transplantation at the University of Pittsburgh Transplantation Institute (1989-1993).
Dr. Ricordi is well-known for inventing the machine that made it possible to isolate large numbers of islet cells from the human pancreas. The procedure is now used by laboratories performing clinical islet transplants. Acknowledged by his peers as one of the world’s leading scientists in islet transplantation, Dr. Ricordi has trained the majority of islet cell transplant researchers worldwide and has developed highly innovative strategies in an attempt to transplant islets without the continuous requirement for immunosuppressive drugs.
Dr. Ricordi is founder and past president of the Cell Transplant Society, co-founder and steering committee member of the International Association for Pancreas and Islet Transplantation (IPITA), and co-founder of the National Diabetes Research Coalition. Dr. Ricordi is also an active member of The Transplantation Society, the American Diabetes Association, the American Federation of Clinical Research, and the American Society of Transplant Surgeons. Additionally, Dr. Ricordi has been a reviewer of application grants for a number of organizations, including the European Economic Community, National Institutes of Health, Canadian Diabetes Association, and the Juvenile Diabetes Foundation.